Statistics for Immuneering (id:6614 IMRX)

Valuation metrics

Market cap

65.21M

Enterprise value

2.11M

Trailing P/E (ttm)

-1.12

Forward P/E

-1.28

PEG ratio

-1.28

Price/Sales (ttm)

Price/Book (mrq)

0.68

Enterprise Value/Revenue

Enterprise Value/EBITDA

-0.04

Overview

Shares outstanding

31.05M

Float

19.11M

Shares short

2.05M

% Held by insiders

0.29%

% Held by institutions

0.30%

Average volume (10 days)

436.06K

Average volume (90 days)

Price summary

52-Week low

1.00

52-Week high

8.89

52-Week change

-275.71%

Beta

-0.40

50-Day moving average

2.22

200-Day moving average

2.28

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-37.42%

Return on equity

-61.81%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-60,089,768.00

Net income to common (ttm)

-56,066,460.00

Diluted EPS (ttm)

-1.97

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

59.73M

Total cash per share (mrq)

2.01

Total debt (mrq)

4.31M

Total Debt/Equity (mrq)

6.50

Current ratio (mrq)

939.20%

Book value per share (mrq)

3.09

Cash flow

Cash flow statement

-50,819,168.00

Levered free cash flow (LFCF)

-31,606,916.00